122 related articles for article (PubMed ID: 20799261)
1. Tuftsin derivatives of FITC, Tb-DOTA or Gd-DOTA as potential macrophage-specific imaging biomarkers.
Feng J; Meloni MM; Allan SM; Faulkner S; Narvainen J; Vidyasagar R; Kauppinen R
Contrast Media Mol Imaging; 2010; 5(4):223-30. PubMed ID: 20799261
[TBL] [Abstract][Full Text] [Related]
2. Novel dual labelled nucleus-directed conjugates containing correct and mutant nuclear localisation sequences.
Sturzu A; Regenbogen M; Klose U; Echner H; Gharabaghi A; Heckl S
Eur J Pharm Sci; 2008 Mar; 33(3):207-16. PubMed ID: 18243673
[TBL] [Abstract][Full Text] [Related]
3. A luminescent probe containing a tuftsin targeting vector coupled to a terbium complex.
Aarons RJ; Notta JK; Meloni MM; Feng J; Vidyasagar R; Narvainen J; Allan S; Spencer N; Kauppinen RA; Snaith JS; Faulkner S
Chem Commun (Camb); 2006 Feb; (8):909-11. PubMed ID: 16479308
[TBL] [Abstract][Full Text] [Related]
4. Novel cell nucleus directed fluorescent tetraazacyclododecane-tetra-acetic acid compounds.
Sturzu A; Klose U; Echner H; Regenbogen M; Kalbacher H; Gharabaghi A; Heckl S
Med Chem; 2009 Jan; 5(1):93-102. PubMed ID: 19149655
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake of cationic gadolinium-DOTA peptide conjugates with and without N-terminal myristoylation.
Sturzu A; Klose U; Echner H; Beck A; Gharabaghi A; Kalbacher H; Heckl S
Amino Acids; 2009 Jul; 37(2):249-55. PubMed ID: 18633572
[TBL] [Abstract][Full Text] [Related]
6. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
[TBL] [Abstract][Full Text] [Related]
7. Receptor-mediated endocytosis of tuftsin by macrophage cells.
Gottlieb P; Hazum E; Tzehoval E; Feldman M; Segal S; Fridkin M
Biochem Biophys Res Commun; 1984 Feb; 119(1):203-11. PubMed ID: 6322775
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of phagocytic activity of murine Kupffer cells by tuftsin.
Kubo S; Rodriguez T; Roh MS; Oyedeji C; Romsdahl MM; Nishioka K
Hepatology; 1994 Apr; 19(4):1044-9. PubMed ID: 8138244
[TBL] [Abstract][Full Text] [Related]
9. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
[TBL] [Abstract][Full Text] [Related]
10. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.
Tan M; Burden-Gulley SM; Li W; Wu X; Lindner D; Brady-Kalnay SM; Gulani V; Lu ZR
Pharm Res; 2012 Apr; 29(4):953-60. PubMed ID: 22139536
[TBL] [Abstract][Full Text] [Related]
11. Specific translocation of tuftsin (Thr-Lys-Pro-Arg), a natural immunomodulating peptide, into the nuclei of human monocytes.
Wagle JR; Ansevin AT; Dessens SE; Nishioka K
Biochem Biophys Res Commun; 1989 Mar; 159(3):1147-53. PubMed ID: 2494998
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of a cell-permeable bimodal contrast agent targeting β-galactosidase.
Keliris A; Ziegler T; Mishra R; Pohmann R; Sauer MG; Ugurbil K; Engelmann J
Bioorg Med Chem; 2011 Apr; 19(8):2529-40. PubMed ID: 21459584
[TBL] [Abstract][Full Text] [Related]
13. A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin-D detection.
Ta R; Suchy M; Tam JH; Li AX; Martinez-Santiesteban FS; Scholl TJ; Hudson RH; Bartha R; Pasternak SH
Contrast Media Mol Imaging; 2013; 8(2):127-39. PubMed ID: 23281285
[TBL] [Abstract][Full Text] [Related]
14. Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.
Fridkin M; Tsubery H; Tzehoval E; Vonsover A; Biondi L; Filira F; Rocchi R
J Pept Sci; 2005 Jan; 11(1):37-44. PubMed ID: 15635725
[TBL] [Abstract][Full Text] [Related]
15. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
[TBL] [Abstract][Full Text] [Related]
16. ADP-ribosylation of tuftsin suppresses its receptor-binding capacity and phagocytosis-stimulating activity to murine peritoneal macrophages.
Terashima M; Hara N; Badruzzaman M; Shimoyama M; Tsuchiya M
FEBS Lett; 1997 Jul; 412(1):227-32. PubMed ID: 9257725
[TBL] [Abstract][Full Text] [Related]
17. Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa.
Demine S; Balhuizen A; Debaille V; Joosten L; Fereau M; Chilla SNM; Millard I; Scharfmann R; Egrise D; Goldman S; Marchetti P; Gotthardt M; Laurent S; Burtea C; Eizirik DL
Molecules; 2018 Aug; 23(9):. PubMed ID: 30134599
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
[TBL] [Abstract][Full Text] [Related]
19. Tuftsin (Thr-Lys-Pro-Arg), a natural modulator of macrophage activity: further studies.
Bump NJ; Najjar VA
Mol Cell Biochem; 1984 Sep; 63(2):137-42. PubMed ID: 6493218
[TBL] [Abstract][Full Text] [Related]
20. Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms.
Dagan S; Tzehoval E; Fridkin M; Feldman M
J Biol Response Mod; 1987 Dec; 6(6):625-36. PubMed ID: 3502474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
